Voyager Therapeutics (VYGR) Change in Cash (2014 - 2026)
Voyager Therapeutics (VYGR) posted Change in Cash of -$22.0 million for Q1 2026, down 227.11% sequentially from $17.3 million in Q4 2025, and down 748.94% YoY from $3.4 million in Q1 2025.
Voyager Therapeutics (VYGR) Change in Cash (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Change in Cash for 13 years, with the latest figure at -$22.0 million in Q1 2026.
- Quarterly Change in Cash fell 748.94% year-over-year to -$22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.6 million (up 53.78% YoY) and the FY2025 annual result came in at -$6.2 million, down 261.34% from the prior year.
- Change in Cash slipped to -$22.0 million in Q1 2026 per VYGR's latest filing, from $17.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $169.4 million in Q1 2023 and troughed at -$179.0 million in Q3 2023.
- A 5-year average of -$4.3 million and a median of $3.4 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2023: Change in Cash tumbled 119673.33% in 2022, then jumped 1072.87% in 2023.
- Over 5 years, Change in Cash stood at $2.1 million in 2022, then surged by 68.32% to $3.5 million in 2023, then sank by 1264.96% to -$41.2 million in 2024, then surged by 142.03% to $17.3 million in 2025, then sank by 227.11% to -$22.0 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$22.0 million, $17.3 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | -7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.55 Mn |
| Mar 31, 2026 | -21.99 Mn |
| Dec 31, 2025 | 17.30 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | -30.82 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | -41.16 Mn |
| Sep 30, 2024 | 36.40 Mn |
| Jun 30, 2024 | -66.95 Mn |
| Mar 31, 2024 | 75.56 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | -179.02 Mn |
| Jun 30, 2023 | -23.95 Mn |
| Mar 31, 2023 | 169.36 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 18.53 Mn |
| Jun 30, 2022 | -53.81 Mn |
| Mar 31, 2022 | 14.44 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Sep 30, 2021 | -6.37 Mn |